The current challenge is to determine which role interaction FLNA plays in the organization of the actin cytoskeleton, cellular signaling and transcription, and to identify the biochemical mechanisms that regulate these interactions for developing inhibitory strategies in particular types of human cancers. The gene discussed is FLNA; the disease is cancer.